No association between the sigma receptor type 1 gene and schizophrenia: Results of analysis and meta-analysis of case-control studies

BMC Psychiatry

Volumn 3, Issue , 2003, Pages

  Uchida, Naohiko ^a,b   Ujike, Hiroshi ^a   Nakata, Kenji ^a   Takaki, Manabu ^a   Nomura, Akira ^a   Katsu, Takeshi ^a   Tanaka, Yuji ^a   Imamura, Takaki ^a,c   Sakai, Ayumu ^a,d   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Seiwakai Nishikawa Hospital   (Japan)

^c Takaoka Hospital   (Japan)

^d Kasaoka Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; GLYCINE; PROLINE; SIGMA 1 OPIATE RECEPTOR; THREONINE;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEBEPHRENIA; HUMAN; HUMAN CELL; JAPAN; MAJOR CLINICAL STUDY; MALE; PARANOID SCHIZOPHRENIA; PATHOGENESIS; POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, SIGMA; SCHIZOPHRENIA; SCHIZOPHRENIA, DISORGANIZED; SCHIZOPHRENIA, PARANOID;

EID: 2642570958     PISSN: 1471244X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-244X-3-13     Document Type: Article

References (17)

1. Martin WR, Eades CE, Thompson JA and Huppler RE: The effects of morphine- and nalorphin-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976, 197:517-532.
2. Walker JM, Bowen WD, Walker FO, Matsumoto RR, De CB and Rice KC: Sigma receptors: biology and function. Pharmacol Rev 1990, 42:355-402.
3. Ujike H, Kanzaki A, Okumura K, Akiyama K and Otsuki S: Sigma (∑) antagonist BMY 14802 prevents methamphetamine-induced sensitization. Life Sci 1992, 50(16):PL-129-PL-134.
4. Ujike H, Okumura K, Zushi Y, Akiyama K and Otsuki S: Persistent supersensitivity of σ - receptors develops during repeated methamphetamine treatment. Eur J Pharmacol 1992, 211:323-328.
5. Ujike H, Kuroda S and Otsuki S: σ Receptor antagonists block the development of sensitization to cocaine. Eur J Pharmacol 1996, 296:123-128.
6. Okuyama S, Ogawa S, Nakazato A and Tomizawa K: Effect of NE-100, a novel sigma receptor ligand, on phencyclidine-induced delayed cognitive dysfunction in rats. Neurosci Lett 1995, 189:60-62.
7. Tam SW: Naloxone-inaccessible sigma receptor in rat central nervous system. Proc Natl Acad Sci U S A 1983, 80:6703-6707.
8. 3H]YM-09151-2 (nemonapride), a potent radioligand for both sigma 1 and sigma 2 receptor subtypes. Neuroreport 1996, 7:1057-1061.
9. Weissman AD, Casanova MF, Kleinman JE, London ED and De SE: Selective loss of cerebral cortical sigma, but not PCP binding sites in schizophrenia. Biol Psychiatry 1991, 29:41-54.
10. Helmeste DM, Tang SW, Bunney WJ, Potkin SG and Jones EG: Decrease in sigma but no increase in striatal dopamine D4 sites in schizophrenic brains. Eur J Pharmacol 1996, 314:R3-5.
11. Modell S, Naber D and Holzbach R: Efficacy and safety of an opiate sigma-receptor antagonist (SL 82.0715) in schizophrenic patients with negative symptoms: an open dose-range study. Pharmacopsychiatry 1996, 29:63-66.
12. Muller MJ, Grunder G, Wetzel H, Muller-Siecheneder F, Marx-Dannigkeit P and Benkert O: Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trial. Psychiatry Res 1999, 89:275-280.
13. Huber MT, Gotthardt U, Schreiber W and Krieg JC: Efficacy and safety of the sigma receptor ligand EMD 57445 (panamesine) in patients with schizophrenia: an open clinical trial. Pharmacopsychiatry 1999, 32:68-72.
14. Ishiguro H, Ohtsuki T, Toru M, Itokawa M, Aoki J, Shibuya H, Kurumaji A, Okubo Y, Iwawaki A and Ota K et al.: Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia. Neurosci Lett 1998, 257:45-48.
15. Ohmori O, Shinkai T, Suzuki T, Okano C, Kojima H, Terao T and Nakamura J: Polymorphisms of the sigma(1) receptor gene in schizophrenia: An association study. Am J Med Genet 2000, 96:118-122.
16. Erdfelder E, Faul F and Buchner A: G POWER: A general power analysis program. Behavior Research Methods, Instruments, and Computers 1996, 28:1-11.
17. Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW and Taylor DP: A proposal for the classification of sigma binding sites. Trends Pharmacol Sci 1992, 13:85-86.